Skip to content

Clinical trials

Phase 2 Gastrointestinal Stromal Tumors trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastrointestinal Stromal Tumors Phase: Phase 2 Clear all

112 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20011
20024
20031
20042
20058
20064
20073
20089
20093
20103
20118
20126
20133
20144
20154
20163
20179
20183
20192
20202
20212
20223
20234
20245
20253
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed66
Recruiting16
Unknown status10
Terminated9
Active, not recruiting5
Not yet recruiting3
Withdrawn2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Asan Medical Center13
National Cancer Institute (NCI)12
Novartis Pharmaceuticals12
M.D. Anderson Cancer Center4
European Organisation for Research and Treatment of Cancer - EORTC3
Sarcoma Alliance for Research through Collaboration3
Astex Pharmaceuticals, Inc.2
Centre Leon Berard2
GlaxoSmithKline2
National Health Research Institutes, Taiwan2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastrointestinal Stromal Tumors112
Sarcoma16
Gastrointestinal Neoplasms7
Neoplasms6
Ovarian Neoplasms6
Stomach Neoplasms6
Leiomyosarcoma5
Neoplasm Metastasis5
Neurofibrosarcoma5
Biliary Tract Neoplasms4

Trials

Showing 76 to 100 of 112. Each trial links to its page on Pharma Observatory.

12 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.